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Unfolding and refolding of plasma vitronectin appear
irreversible under near physiological conditions, with
rearrangements of disulfides and self-association to a
multimeric form observed as prominent structural alterations which accompany denaturation. A mechanism
for the folding reactions of vitronectin has been proposed (Zhuang, P., Blackburn, M. N., and Peterson, C. B.
(1996) J. Biol. Chem. 270, 14323–14332) in which vitronectin acquires a partially folded intermediate structure
which is highly prone to oligomerize into a multimeric
form. Strongly oxidizing conditions adopted for refolding from urea were effective at preventing disulfide rearrangement which disrupts distal disulfides near the C
terminus of the protein. Prohibiting disulfide rearrangement under these conditions, however, was not
sufficient to achieve reversibility in folding. In contrast,
variations in the ionic strength of the refolding medium
affect the partitioning of species so that refolded monomers are obtained at high ionic strength, and self-association is precluded. The effects of ionic strength on the
partially folded intermediate in the vitronectin folding
pathway appear to favor intramolecular hydrophobic
collapse to form a stable hydrophobic core for the monomer versus intermolecular hydrophobic interactions
which stabilize multimeric vitronectin. Although both
ionic and hydrophobic interactions presumably contribute to subunit interfaces within the multimer, the basic
heparin-binding region near the C terminus of the protein does not provide binding interactions which are
important for self-association of vitronectin.

Vitronectin is a multi-functional protein which is found in a
plasma form, which circulates in the bloodstream at high concentrations, and in tissue forms, which are present within
platelets, deposited into the extracellular matrix of endothelial
cells, or localized to other extravascular sites. The multiple
functions of vitronectin are a manifestation of specific interac-
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tions with many other macromolecules, including the integrin
class of receptors on cells, the inactive antithrombin-thrombin
complex, the terminal membrane attack complex of complement, collagen and other extracellular matrix components,
plasminogen activator inhibitor type 1, and the mucopolysaccharide, heparin. Binding of these target ligands appears to be
modulated through alterations in the conformation of vitronectin, an observation that was originally noted for interactions
with heparin (1, 2) and subsequently extended to other physiologically relevant macromolecules (reviewed in Refs. 3– 6).
Monoclonal antibodies have been useful to demonstrate the
conformational lability of vitronectin (7–10), which has been
characterized using chemical or thermal denaturation methods
to mimic the more physiologically relevant stimuli for structural rearrangement. Justification for this approach came
early in the evaluation of structural changes in vitronectin,
with the demonstration by Tomasini and Mosher (7) using
monoclonal antibody 8E6 that conformational alterations induced upon treatment with urea were similar to those observed
upon association of vitronectin with the antithrombin-thrombin complex. Comparison between plasma vitronectin and tissue-associated forms is by no means complete, but several
recent studies have indicated that non-circulating forms of the
protein exist in the structurally-altered form, detected by several conformation-specific monoclonal antibodies, including the
8E6 prototype (11).
The structural basis for the conformational lability of
vitronectin is incompletely understood. Alterations in the conformation of vitronectin induced by chemical denaturation are
notably accompanied by self-association to form vitronectin
multimers in vitro (9, 11–13). In a companion paper (12), spectroscopic methods were used to characterize structural changes
which accompany unfolding and subsequent refolding of purified plasma vitronectin. Unfolding and refolding curves generated by varying concentrations of chemical denaturants were
non-coincident, although precautions were taken to ensure
complete unfolding prior to renaturation. Refolding from high
denaturant concentrations was accompanied by association to
a multimeric form of vitronectin with an average molecular
weight of 420,000. The hysteresis observed is indicative of
different pathways for unfolding versus refolding and/or the
conversion of vitronectin from one stable form to a second,
differently folded structure.
Scheme 1 can be used to describe the folding and self-association of vitronectin. V represents the native, monomeric form
of vitronectin, V* an intermediate, partially folded form of the
protein, U the fully unfolded form, and Mv, the multimeric form
of vitronectin. Folding of vitronectin appears to be regulated by
partitioning of folding intermediates toward either of two conformations, one that exists as a stable monomer and another
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SCHEME 1

that associates into a multimeric form. Partial unfolding of
vitronectin results in a pronounced tendency for the protein to
self-associate, and refolding of the protein following chemical or
thermal denaturation is invariably accompanied by oligomerization to the multimeric form at physiological ionic strengths.
This study expands on the work which germinated Scheme I to
consider the following questions. Does intramolecular disulfide
rearrangement stabilize an alternative fold with a tendency to
multimerize? Are there conditions which favor refolding of
vitronectin to a monomeric form without self-association as a
prominent side reaction? What effect do charged biomolecules
or salts have on the distribution of refolded vitronectin between
monomeric and multimeric forms? What contributions do ionic
and hydrophobic interactions make to the process of self-association of vitronectin? Does the heparin-binding region of
vitronectin contribute intermolecular interactions which participate in oligomerization to the multimeric form? Analytical
and immunochemical approaches have been used to address
these questions and gain insight into the mechanism by which
multimeric vitronectin is produced.
EXPERIMENTAL PROCEDURES

Materials—Vitronectin was purified by a modification of the original
procedure of Dahlback and Podack (14), essentially as described by
Bittorf et al. (9). The modifications of Bittorf et al. (9) include addition
of DTNB1 during the preparation to block available sulfhydryls on
vitronectin which were originally reported in the Dahlback and Podack
(14) purification. Note that Bittorf et al. (9) indicate that there is not
clear evidence that DTNB is maintained on vitronectin throughout the
protein preparation, since reduction of the purified vitronectin sample
with dithiothreitol was not accompanied by release of the thionitrobenzoate anion (9). Purity was assessed by sodium dodecyl sulfate-polyacrylamide gel electrophoresis in the presence of b-mercaptoethanol (15).
A molecular weight for the protein of 72,000 and an extinction coefficient of 1.02 mlzmg21zcm21 were used for purified vitronectin (12). The
number of free sulfhydryls in purified vitronectin was determined under native, denaturing, or reducing conditions using DTNB (16). Multimeric vitronectin was prepared by treatment of protein in 8 M urea at
room temperature for 2 h, with subsequent removal of denaturant by
dialysis into standard phosphate buffer (0.1 M sodium phosphate, pH
7.5, containing 0.15 M NaCl and 1 mM EDTA). Heat-denatured vitronectin was prepared by incubating the protein in phosphate-buffered saline
(40 mM sodium phosphate, pH 7.4, containing 0.15 M NaCl) or standard
phosphate buffer at 55 °C for 1–2 h and subsequent cooling on ice (10,
11).
The 18-residue peptide which corresponds to amino acids 346 to 363
in vitronectin, LAKKQRFRHRNRKGYRSQ, was purchased from Chiron Mimetopes. The peptide from the commercial vendor was greater
than 85% pure and was used without further purification. The amino
acid sequence of the peptide was confirmed by amino acid analysis and
NMR characterization, and heparin binding activity was established by
fluorescence methods during the initial structural work on the peptide.2
Ultrapure guanidine hydrochloride was purchased from Life Technologies, Inc. Urea was a product of ICN Biomedical. 125I-Labeled sheep
anti-mouse IgG was from Amersham; biotin-conjugated goat anti1
The abbreviations used are: DTNB, dithionitrobenzoate; GdnHCl,
guanidine hydrochloride; PAGE, polyacrylamide gel electrophoresis;
GSH and GSSG, the reduced and oxidized forms of glutathione, respectively; mAb, monoclonal antibody; ELISA, enzyme-linked immunosorbent assay; Cpn60 and Cpn70, charperonins 60 and 70 (sometimes
referred to as Hsp60 and Hsp70); HPLC, high performance liquid
chromatography.
2
J. A. Lamerdin, C. B. Peterson, and E. H. Serpersu, submitted for
publication.

mouse IgG, streptavidin-alkaline phosphatase conjugate, and p-nitrophenyl phosphate were from Zymed. All other chemicals were of reagent grade quality.
Immunochemical Analyses—Monoclonal antibodies (mAbs) 153 and
1244 were obtained by standard hybridoma techniques using denatured
vitronectin as the immunogen (17), and the hybridoma clone producing
mAb 8E6 was kindly provided by Dr. Deane Mosher (University of
Wisconsin). MAbs were produced as ascites, and the resulting IgG was
purified by using protein A-agarose (mAbs 153 and 1244) or by the
caprylic acid method (mAb 8E6) (18).
Native PAGE was performed using a 3% polyacrylamide stacking gel
and 7.5% polyacrylamide resolving gel run in the Laemmli buffer system (15) without SDS. For Western blotting, proteins in the gel were
transferred onto nitrocellulose membranes and analyzed using mAb
1244 as described (17). Binding of the anti-vitronectin antibodies was
detected using 125I-labeled sheep anti-mouse IgG.
Conformational changes in vitronectin were quantified by a competitive ELISA method principally as described (7, 9, 10), in which mAb
binding is partitioned between denatured vitronectin coated on microtiter wells and competing vitronectin in solution. Bound IgG was detected with biotin-conjugated goat anti-mouse IgG, followed by streptavidin-alkaline phosphatase conjugate, and the substrate p-nitrophenyl
phosphate in a final step. In the concentration range used for the
experiments, the addition of amino acids or NaCl did not interfere with
the binding of mAbs to immobilized vitronectin; neither did the added
reagents remove coated vitronectin from the microtiter wells.
Variation of Redox Conditions for Unfolding—Vitronectin at a concentration of 5 mM was treated overnight with 5 M urea, a concentration
of denaturant very near the midpoint in the unfolding curve (12) which
has been shown to lead to rearrangement of disulfides (9). Various
combinations of oxidized and reduced glutathione were added along
with 5 M urea to individual vitronectin samples to vary the redox
potential during unfolding from strongly oxidizing to strongly reducing
potentials. Urea solutions were made fresh for each experiment. Redox
potential was calculated from the Nernst equation as follows,
Eh 5 E° 1 ~2.303RT/nF! 3 log~@GSSG#/@GS2#2!

(Eq. 1)

in which E°, the standard redox potential for glutathione is 20.24 V
(19), n equals 2, R is the gas constant, 8.314 JzK21zmol21, and F is
Faraday’s constant, 97,485 Czmol21. Samples were analyzed for disulfide rearrangement on 10% SDS-PAGE gels in which samples were
prepared in loading buffer without added reducing agents (i.e. nonreducing SDS-PAGE). Electrophoresis was performed according to
Laemmli (15).
Analytical Gel Filtration Analyses—Native and multimeric proteins
were analyzed by HPLC using a Beckman ultraspherogel SEC2000
column (7.5 mm x 30 cm) at a flow rate of 1 mlzmin21 in standard
phosphate buffer. Samples were generally 1 mgzml21 in concentration,
and 20-ml samples were analyzed per run. Elution of protein from the
column was monitored by absorbance at 280 nm. Retention times characteristic of monomeric and multimeric vitronectin were 6.8 6 0.1 and
5.6 6 0.1 min, respectively.
In a similar fashion, analytical gel filtration was performed in some
experiments using a Superose-12 column (1 3 30 cm; 23.7-ml bed
volume) with a Pharmacia FPLC system. Vitronectin (1 mgzml21) was
denatured for 16 h in 5 M urea in standard phosphate buffer, and the
same denaturant solution was used for chromatography at flow rates of
0.5 mlzmin21. Duplicate experiments were performed in 5 M urea in
standard phosphate buffer plus 10 mM GSSG. Initial sample volume
applied to the column was 0.5 ml or less. Protein elution patterns were
detected by monitoring absorbance at 280 nm.
Fluorescence Analysis of Chemical Denaturation of Vitronectin—Unfolding and refolding of vitronectin were induced by GdnHCl and monitored by changes in intrinsic protein fluorescence, as described (12).
Buffer used for the unfolding and refolding experiments was standard
phosphate buffer containing 0.04% Tween 20. For experiments to test
the effects of limiting disulfide rearrangement, the same buffer was
used with the addition of 10 mM GSSG. Aliquots from a concentrated
protein stock were diluted to a final concentration of 0.5 mM protein in
varying concentrations of denaturant. Samples were incubated at room
temperature overnight to ensure complete unfolding before the measurements were made. For refolding studies, vitronectin was first unfolded in 7 M GdnHCl in standard phosphate buffer plus 10 mM GSSG
for 16 h. Aliquots of vitronectin in 7 M GdnHCl were then diluted 10-fold
into mixtures of buffer and GdnHCl solution, both containing 10 mM
GSSG, and again incubated overnight. GdnHCl concentrations were
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TABLE I
Determination of free sulhydryls in native and denatured vitronectin
(mol TNB)/(mol protein)a

Experimental conditions

Buffer only

0.08
0.00
2.00
12.87
11.28

b

Denaturing
Denaturing and reducingc

a
Mol of thionitrobenzoate anion released per mol of protein. Values
listed represent separate determinations on replicate samples.
b
Vitronectin was unfolded in 6 M urea for 4 h as described under
“Experimental Procedures.”
c
Vitronectin was unfolded in 6 M urea with 10 mM dithiothreitol as
described under “Experimental Procedures.”

calculated using equations relating refractive indexes to concentrations
(20), and refractive indexes were measured using a Zeiss refractometer.
RESULTS

Adjustments in Redox Conditions Limit Disulfide Rearrangements Which Are Observed upon Urea Treatment of Vitronectin—Although vitronectin has been proposed to contain cysteines in a combination of oxidized disulfides and reduced -SH
forms, the number of free sulfhydryls in vitronectin has been
disputed (9, 14, 21). In order to quantitate free sulfhydryls in
the purified protein used for these experiments, vitronectin
was treated with DTNB under native and denaturing conditions. Native vitronectin was found to have essentially no available free sulfhydryls, consistent with previous observations (9),
whereas vitronectin denatured in 6 M urea contained 2 sulfhydryls (Table I). These results indicate that vitronectin contains
a mixture of oxidized and reduced sulfur groups, and that the
free sulfhydryls are buried in the native protein. It is not until
vitronectin is denatured that these sulfhydryls are exposed and
available to promote disulfide rearrangement in the protein.
DTNB reactions on fully denatured and reduced vitronectin
gave an average of 12.1 -SH groups per protein molecule, in fair
agreement with the 14 sulfhydryls expected from the known
sequence of the protein (22).
Under near physiological buffer conditions, refolding of
vitronectin from either a chemically-denatured or heat-denatured state proceeds via an intermediate which is partially
folded and highly prone to self-associate into a multimeric
form. It was noted early in the work on urea denaturation of
vitronectin that disulfide rearrangement occurs upon chemical
treatment (7, 8). This observation was made from SDS-PAGE
run under non-reducing conditions in which disulfide rearrangement disrupts interchain cross-links between the 62,000
and 10,000 polypeptide chains of vitronectin and two polypeptides are observed on gels rather than a single 72,000 species.
Although disulfide rearrangement could result in intermolecular cross-linking of constituent proteins within multimeric
vitronectin, only a minority of chains within the multimer are
linked by disulfide bonds (12) so that the multimer is not
uniformly cross-linked.
Although intermolecular disulfides are not uniform within
the multimer and thus do not fully account for assembly of the
multimer, the possibility exists that intramolecular disulfide
rearrangement stabilizes an alternative conformation of
vitronectin which is prone to self-associate upon refolding. To
test this hypothesis, variations in redox potential during unfolding and refolding were used to define conditions which
prohibit disulfide rearrangement. Fig. 1 shows the effects of
varying redox potential with GSH and GSSG during unfolding.
A clear trend is observed in which appearance of the 62,000
chain upon release of the 10,000 fragment is minimized as
unfolding reactions are conducted under strongly oxidizing conditions. Under the most highly oxidizing conditions tested,

FIG. 1. Variations in redox potential affect rearrangement of
disulfides in vitronectin induced by urea treatment. Vitronectin
was unfolded in 5 M urea for 16 h in the absence or presence of added
glutathione. Gel-loading buffer (50 mM Tris, pH 6.8, containing 2% SDS,
0.1% bromphenol blue, and 20% glycerol) without reducing agents was
added in an equal volume to the samples. The samples were boiled for
5 min before loading onto the 10% polyacrylamide gel. Following electrophoretic separation, proteins were visualized by staining with Coomassie Brilliant Blue R-250. Lane 1 contains untreated vitronectin with
no denaturant or glutathione added, and lane 10 represents vitronectin
which has been denatured in urea without addition of glutathione.
Concentrations of GSSG and GSH were adjusted to vary the redox
potential as follows: lane 2, 10 mM GSSG; lane 3, 10 mM GSSG, 0.01 mM
GSH; lane 4, 10 mM GSSG, 0.1 mM GSH; lane 5, 5 mM GSSG, 0.01 mM
GSH; lane 6, 5 mM GSSG, 0.1 mM GSH; lane 7, 1 mM GSSG and 0.1 mM
GSH; lane 8, 1 mM GSSG and 1 mM GSH. Redox potentials for unfolding
solutions in lanes 2– 8 are 0, 0, 260, 210, 270, 290, and 2150 mV,
respectively. The sample in lane 10 is native vitronectin which was
prepared in gel-loading buffer containing 100 mM dithiothreitol as a
control for migration of the 72,000 and 62,000 forms of vitronectin upon
disruption of the disulfide-bonded (62,000 1 10,000) form.

disulfide rearrangement appears to be prohibited. Exposed
sulfhydryls are prevented from catalyzing intramolecular disulfide rearrangement within vitronectin due to the great excess of glutathione, which provides a small molecular weight
substrate for disulfide exchange and formation of mixed
disulfides.
The results of the SDS-PAGE were confirmed by using analytical gel filtration to test for dissociation of the disulfide
cross-linked two-chain form of vitronectin to separated 62,000
and 10,000 chains upon denaturation in 5 M urea plus or minus
10 mM GSSG (Fig. 2). Under normal denaturation conditions
without added glutathione, urea treatment results in disruption of the covalent disulfide cross-link between the 62,000 and
10,000 chains of vitronectin, so a late eluting peak corresponding to the 10,000 polypeptide is clearly seen on analytical gel
filtration. In contrast, addition of oxidized glutathione to the
denaturation mixture prevented the disulfide rearrangement
which leads to release of the 10,000 C-terminal fragment, and
a single peak corresponding to a 72,000 species was observed in
analytical gel filtration under these conditions. Within the
limitations of these assays, it appears that highly oxidizing
conditions conferred during unfolding of vitronectin prohibit
intra- or intermolecular disulfide rearrangement.
Irreversibility of Unfolding/Refolding of Vitronectin Is Not
Solely due to Disulfide Rearrangement—Hysteresis between
unfolding and refolding curves was noted in the absence of
GSSG and can be attributed either to the possibility that the
two processes proceed via different pathways or to the prospect
of a different fold for native compared to denatured/renatured
vitronectin. Since oxidizing conditions prevented disulfide rearrangement, GSSG was included in the denaturation mixtures, and unfolding and refolding behavior were tested as a
function of GdnHCl by monitoring changes in intrinsic fluorescence of the protein (12). The results shown in Fig. 3 exhibit
hysteresis between unfolding and refolding curves, demonstrating that inclusion of GSSG in the reactions to stem disul-
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FIG. 2. Analytical gel filtration indicates that strongly oxidizing conditions prevent release of the 10,000 C-terminal fragment via disulfide rearrangement. Vitronectin (1 mgzml21; 0.2 ml)
was denatured overnight in 5 M urea (panel A) or 5 M urea containing 10
mM GSSG (panel B). The sample was subsequently chromatographed by
HPLC at room temperature on a Superose 12 column equilibrated in the
urea solution with or without GSSG as appropriate for the two samples.
The elution profile was monitored by absorbance at 280 nm, shown on
the y axis. Arrows mark the elution volume for molecular weight standards: a, ferritin (Mr 5 440,000); b, catalase (Mr 5 232,000); c, bovine
serum albumin (Mr 5 67,000); d, ovalbumin (Mr 5 43,000); e, chymotrypsinogen A (Mr 5 25,000); f, ribonuclease A (Mr 5 13,700).

fide rearrangement does not lead to reversible unfolding/refolding behavior. Midpoints for the denaturation curves and
intensity-averaged wavelengths corresponding to folded and
unfolded protein are summarized in Table II. Values are also
listed in Table II for GdnHCl unfolding/refolding curves generated without GSSG (12); parameters describing unfolding and
refolding of vitronectin in GdnHCl are virtually indistinguishable regardless of addition of GSSG.
Charged Amino Acids Influence the Partitioning between
Monomers and Multimers upon Refolding of Heat-denatured
Vitronectin—Comparison of unfolding curves for vitronectin in
GdnHCl and urea indicated differences in the cooperativity of
denaturation (i.e. different slopes in the transition region in
unfolding curves), in which unfolding in urea occurred over a
much broader concentration range than in GdnHCl (12). Although both denaturants are chaotropes, GdnHCl is also a salt.
Differences in the nature of the denaturants might account for
the differences in the unfolding curves, with the possibility that
ionic effects of GdnHCl may affect the folding of vitronectin.
Postulated influences of ionic strength on folding of the protein
prompted evaluation of effects of ionic compounds, including
charged amino acids and NaCl, on denaturation and
renaturation.
Native vitronectin was denatured by heat treatment in the
presence or absence of selected amino acids, and the extent of
the resulting multimerization was evaluated by native PAGE
(Fig. 4). As has been previously observed (11), heat treatment
induced the formation of high molecular weight multimers that
only partially entered the separating gel and thus were easily
distinguished from native vitronectin which migrates as two or
three predominant bands in native gels.3 Upon heat treatment
3
Native vitronectin appears polydisperse on these native gels due to
reasons that are incompletely understood. It has been our observation
that monomeric vitronectin which is determined to be homogeneous
with respect to molecular weight upon equilibrium analytical centrifu-

FIG. 3. GdnHCl unfolding/refolding curves for vitronectin in
the presence of GSSG. Unfolding of purified native vitronectin (closed
circles) in varying concentrations of GdnHCl with a constant concentration of 10 mM GSSG was monitored by average tryptophan emission
wavelength, as described under “Experimental Procedures.” For refolding data (open triangles), proteins were initially denatured in 7 M
GdnHCl plus 10 mM GSSG, and refolding was subsequently initiated by
diluting a 5 mM protein stock 10-fold in mixtures of buffer and denaturant to give final GdnHCl concentrations from 0.7–7 M GdnHCl with
GSSG. Following overnight incubation of vitronectin at each concentration of denaturant in buffer, emission spectra were recorded from 300 to
450 nm using an excitation wavelength of 290 nm. Data are expressed
as Fapp, the apparent fraction unfolded, by normalization of individual
readings to lF and lU as given in Table II, to facilitate comparison
between unfolding and refolding data.

of vitronectin in the presence of charged amino acids, selfassociation of vitronectin was not observed as a prominent side
reaction accompanying refolding, and the electrophoretic mobilities of the resultant vitronectin preparations were relatively
unchanged in comparison to native, untreated vitronectin. In
contrast, the non-polar amino acid glycine had no effect on the
redistribution toward a monomeric form upon refolding, and
multimers were readily formed. The prevention of self-association of vitronectin by charged amino acids was not restricted
to a purified protein system, but was also apparent in plasma
or serum (data not shown). Control experiments were used to
demonstrate that the amino acids had no effect on the migration of multimeric vitronectin if added subsequent to heat
treatment and cooling (data not shown).
Significantly, the monomeric vitronectin obtained after refolding at high concentrations of arginine appeared stable as a
monomer, even after dialysis to remove the charged amino acid
(Fig. 5, panel A). Thus, it is the process of refolding, rather than
the stability of the refolded monomer, that is affected by Larginine. The refolding pathway toward a monomer is preferred versus self-association to a multimer when arginine is
present, and the final folded protein is stable in the absence of
added charged amino acids.
gation (12) migrates as at least two bands on native polyacrylamide
gels. The fact that purified plasma vitronectin exists as a mixture of
single-chain and two-chain, disulfide cross-linked forms may contribute
to the observed homogeneity. Also, it is not known how much potential
variability in glycosylation contributes to anomalies in electrophoretic
migration of vitronectin in this gel system. Furthermore, it remains
unclear to what extent the formation of high local vitronectin concentrations at the interface between stacking and separating phases of the
gel may facilitate partial multimerization during electrophoresis. Fractionation of the vitronectin used for these gels by SDS-PAGE under
non-reducing conditions revealed that 5% or less of the vitronectin
preparation existed as disulfide-linked oligomers.
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TABLE II
Behavior of native and multimeric vitronectin in chemical denaturation/renaturation experiments
Denaturant

Midpoint (M)

lFb

lUb

Unfolding conditions

0.5
0.5
0.5
0.5
0.5
0.5

c

GdnHCl
GdnHCl/GSSGd
GdnHCl
GdnHCl
GdnHCl
GdnHCl

3.2
3.0
2.2
2.6
3.0
3.0

349.7
350.0
352.2
351.9
351.1
349.5

363.8
363.5
360.0
361.9
363.0
362.2

Refolding conditionse

0.5 mM nativec
0.5 mM native

GdnHCl
GdnHCl/GSSGd

2.1
2.0

352.1
352.0

360.7
360.5

Vitronectin samplea

mM
mM
mM
mM
mM
mM

native
native
multimerc
heat-treatedc
heat-treated/refolded in 1 M NaCl
urea treated/refolded in 1 M NaCl

a
Samples are labeled according to the state of the starting material for the experiment as: native, corresponding to the untreated monomeric
protein; multimer, corresponding to urea treated protein which is subsequently renatured at physiological ionic strength; and heat treated,
corresponding to the protein heated to 55 °C and cooled at physiological ionic strength as described under “Experimental Procedures,” heattreated/refolded protein has been heated at 55 °C and cooled to room temperature in buffer containing 1 M NaCl; urea-treated/refolded protein has
been denatured overnight in 8 M urea followed by dialysis into 0.1 M sodium phosphate, pH 7.5, containing 1 mM EDTA and 1 M NaCl.
b
The intensity averaged wavelength corresponding to folded, F, or unfolded, U, protein. Error limits on these measurements are 6 0.2 nm.
c
Unfolding parameters taken from Zhuang et al. (12).
d
Unfolding or refolding experiments were conducted by varying the GdnHCl concentration in standard phosphate buffer containing 10 mM
GSSG.
e
For refolding experiments, protein was initially denatured in 7 M GdnHCl for 16 h. The vitronectin sample types listed thus correspond to the
starting material which was initially denatured prior to the refolding experiment.

FIG. 4. Prevention of vitronectin self-association by charged
amino acids. Native vitronectin was heat treated at 55 °C for 1 h at pH
7.4 and fractionated by native PAGE. Immunoblotting was performed
using mAb 1244 followed by 125I-labeled sheep anti-mouse IgG. The
interface between stacking and resolving gel is indicated by the arrowheads. The untreated native protein is shown in lane 1. Heat treatment
of vitronectin was performed in phosphate-buffered saline (lane 2), 500
mM glycine (lane 3), 500 mM L-lysine (lane 4), 500 mM L-arginine (lane
5), 500 mM L-histidine (lane 6), 500 mM L-aspartic acid (lane 7), or 500
mM L-glutamic acid (lane 8).

Refolding of Vitronectin to a Monomeric versus Multimeric
Form Is a Function of Ionic Strength—Preferential refolding to
a monomeric form was dose-dependent with respect to the
charged amino acid concentration (Fig. 5, panel B, and Fig. 7,
inset). A significant alteration in the bias away from self-association toward a preferred monomeric form was observed at
concentrations of arginine greater than 100 mM. The effect of
charged amino acids was compared to that of NaCl, and doseresponse experiments with NaCl demonstrate that NaCl was
as effective as the charged amino acids in preventing selfassociation of vitronectin (Fig. 5, panel B). The effects of
charged amino acids thus appear most likely to be manifestations of an ionic strength effect similar to that observed with
NaCl. Indeed the ionic strength of a solution of 0.5 M L-arginine,
pH 7.4, was calculated to be equivalent to that for a 1.0 M NaCl
solution.4
4
Ionic strength was calculated as: m 5 1/2S(mizzi2), in which mi
represents the molar concentration, and zi represents the charge on the
species, i. pK values of 2.3, 9.6, and 12.0 were used to calculate the
effective ion concentrations at pH 7.4 for the carboxyl, a-amino, and
guanidino side chain. The pH of the arginine solution was adjusted with
measured aliquots from standardized HCl solutions so that the contri-

FIG. 5. Variations in ionic strength have similar effects to
varying concentrations of L-arginine in preventing multimerization of vitronectin. Panel A, native vitronectin was heat-treated in
the presence of 500 mM L-arginine and analyzed by native PAGE (lane
1). Following heat treatment with arginine, a duplicate sample was
dialyzed into phosphate-buffered saline and analyzed on the gel (lane
2). Panel B, native vitronectin was heat-treated in the presence of 500
mM L-arginine (lane 1), 250 mM L-arginine (lane 2), 125 mM L-arginine
(lane 3), or 500 mM NaCl (lane 4), 250 mM NaCl (lane 5), or 125 mM NaCl
(lane 6). For both panels, the vitronectin samples were fractionated by
native PAGE followed by immunoblotting using mAb 1244 as in Fig. 4.
The interface between stacking and resolving phases of the gel is
indicated by the arrowheads.

Because of the difficulties in a straightforward interpretation of the electrophoretic migration patterns of native
vitronectin on native gels,3 a more analytical approach was
sought to characterize the size and quantitate the molecular
species achieved after refolding vitronectin under various conditions. Analytical gel filtration by HPLC has proven to be an
ideal method to characterize the conditions which lead to multimerization, as the multimer and monomer are adequately
separated and quantitated by the system. The effect of variations in NaCl concentration on the distribution of refolded
vitronectin species between multimers and monomers is shown
in Fig. 6. As had been previously established, refolding at
physiological ionic strengths yields predominantly a multimeric form of vitronectin. However, increasing NaCl concentration from 0.15 to 1.5 M yielded essentially all monomeric
vitronectin upon refolding.
bution of the counterion to solution ionic strength could be directly
quantitated. The ionic strength of heparin (Mr ;6000) was calculated
using an average charge density of 3 negative charges per disaccharide
repeat at near neutral pH values and an approximate molecular weight
of 432 for a disaccharide unit.
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FIG. 6. Effects of ionic strength on the partitioning between
monomer and multimer upon renaturation of vitronectin.
Vitronectin (1 mgzml21) was heat treated for 1 h in 0.1 M sodium
phosphate buffer, pH 7.5, containing 1 mM EDTA and 0.15 M NaCl
(panel A), 0.5 M NaCl (panel B), 1 M NaCl (panel C), or 1.5 M NaCl (panel
D). Samples were cooled to room temperature and 20-ml volumes were
injected onto the SEC2000 column as described under “Experimental
Procedures.” Elution was monitored at 280 nm and is plotted as a
function of time following sample injection. Arrows mark the elution
times for molecular weight standards: a, blue dextran 2000 (Mr 5 2 3
106); b, ferritin (Mr 5 440,000); c, catalase (Mr 5 232,000); d, bovine
serum albumin (Mr 5 67,000); e, ovalbumin (Mr 5 43,000); f, chymotrypsinogen A (Mr 5 25,000).

Results from the HPLC analyses are summarized in Table
III. As shown in the table, the effects of NaCl or L-arginine are
not restricted to refolding of vitronectin following heat-induced
denaturation, as unfolding/refolding experiments performed
using urea with high concentrations of NaCl or L-arginine
result in preferential folding to a monomeric species. Furthermore, the analytical HPLC method clearly substantiates the
result initially observed on gels, that removal of salt following
refolding to a monomer is not conducive to self-association.
That is, once a monomeric form is achieved upon refolding at
high ionic strength, the salt is no longer necessary to stabilize
the monomer and can be removed by dialysis with no effects on
the molecular size or aggregation state of vitronectin. As had
been initially observed on native gels, addition of 1 M NaCl does
not dissociate multimeric vitronectin into constituent monomers, even at long time periods. Also, heat treatment of the
multimer at 55 °C for 1 h in the presence of added NaCl in high
concentrations does not reverse the effects of self-association to
yield a monomeric form of vitronectin.
Conformationally Sensitive MAbs Indicate a Native-like
Structure for Vitronectin Refolded in Vitro at High Ionic
Strength—Multimerization of vitronectin is closely linked to
structural alterations which can be detected using conformationally sensitive mAbs (9 –11). The effect of L-arginine on the
heat-induced expression of conformationally sensitive epitopes
was determined in competitive ELISA experiments (Fig. 7).
Vitronectin was heat-treated in the presence of varying concen-

trations of L-arginine and the resulting vitronectin samples
were assessed for their ability to compete for binding of mAbs
with immobilized, denatured vitronectin. Arginine prevented
the expression of the conformationally-sensitive mAb 8E6
epitope, localized to the connecting region/first hemopexin repeat, in a dose-dependent manner similar to the dose-dependent behavior observed on native gels (see Fig. 7, inset). Similarly, another charged amino acid, L-glutamic acid, was
observed to interfere with heat-induced expression of the 8E6
epitope; effects of selected amino acids on epitope expression
following heat-denaturation are summarized in Table IV. Thermally-induced expression of another conformationally sensitive
epitope, located in the N-terminal somatomedin B domain
(mAb 153), was also prevented by charged amino acids,
whereas expression of either epitope was not influenced by the
presence of L-glycine during denaturation/renaturation. The
inclusion of high concentrations of NaCl during thermal denaturation was shown to prevent expression of these epitopes in
a similar fashion to the charged amino acids (Table IV), again
supporting the notion that the charged amino acids influence
the distribution of refolded species to monomeric and multimeric forms via an ionic strength effect. It should be noted that in
control experiments, polar amino acids added to multimeric
vitronectin after heat denaturation and cooling did not affect
the ability of the multimer to bind mAbs in the competitive
ELISA (data not shown).
Monomers Recovered from Thermal or Chemical Denaturation/Renaturation at High Ionic Strength Exhibit Similar
Stabilities—Thermal and chemical denaturation of vitronectin
has been shown to lead to multimers which differ in size and
stability after self-association at physiological ionic strength
(12). An obvious point of curiosity, therefore, is whether the
monomers, which can be recovered upon either heat or chemical treatment followed by renaturation in high salt, differ in
folding and stability. To compare stability of the renatured
monomers, intrinsic fluorescence of the proteins was monitored
as a function of GdnHCl concentration (Fig. 8). In striking
contrast to the unfolding curves comparing multimers generated by heat or chemical denaturation, which exhibit different
midpoints and shapes, the unfolding curves for the two types of
renatured monomers are identical. Midpoints for denaturation
and average emission wavelengths associated with the folded
and unfolded monomers are summarized in Table II for comparison with other folding curves (12). GdnHCl-induced unfolding of the refolded monomers closely resembles the denaturation of native vitronectin and differs markedly from the
behavior of multimers upon GdnHCl treatment.
Neither Heparin, nor a Peptide Representing the Heparinbinding Region of Vitronectin, Is Effective at Biasing the Refolding Pathway toward Monomeric Vitronectin—To test the
involvement of the heparin-binding region of vitronectin in
self-association, vitronectin was denatured and renatured in
the presence of saturating concentrations of heparin. A rationale for this experiment was that heparin will bind to the arginine-rich heparin-binding sequence near the C terminus which
is exposed upon denaturation of vitronectin. It is well established that denatured vitronectin binds to heparin with reasonable affinity (1, 2). If heparin is bound to a site involved in
intermolecular interactions which stabilize the multimeric
form of vitronectin, then its binding should interfere with the
self-association process. In contrast, as shown by the results of
analytical gel filtration in Table III, heparin did not shift the
distribution of vitronectin toward the monomeric form upon
refolding. This experiment was performed at approximately 50

Redox Potential and Ionic Strength Affect Vitronectin Folding

14339

TABLE III
Analytical gel filtration analysis by HPLC on vitronectin samples
Denaturation conditionsa

Vitronectin sampleb

Heat treatment

Native

Multimer
Refolded
Urea treatment

Native

Refolded
No denaturation

Native

Multimer

Folding/multimerization
conditionsc

Percentage multimeric
vitronectind

0.15 M NaCl
0.5 M NaCl
1.0 M NaCl
1.5 M NaCl
2.0 M NaCl
500 mM L-argininee
100 mM heparin
500 mM peptidef
1.0 M NaCl
1.5 M NaCl, changed tog
0.15 M NaCl

100
36
12
8
7
15
100
100
100
9

0.15 M NaCl
1.0 M NaCl
1.5 M NaCl
500 mM L-arginine
100 mM heparin
490 mM peptidef
1.5 M NaCl, changed tog
0.15 M NaCl

100
40
5
26
100
100
5

5 mM heparinh
100 mM heparinh
5 mM peptidef,h
500 mM peptidef,h
1.0 M NaCli

0
0
0
0
100

21

For heat treatment, 1 mg z ml vitronectin was heated to 55 °C for 1 h and then cooled to room temperature. Urea treatment was performed
by unfolding vitronectin (1 mg z ml21) in 8 M urea overnight.
b
Samples are labeled according to the state of the starting material for the experiment as: native, corresponding to the untreated monomeric
protein; multimeric, corresponding to the chemically denatured then renatured form of the protein; and refolded, corresponding to vitronectin that
was heat-treated at 55 °C for 1 h and cooled to room temperature in 0.1 M sodium phosphate, pH 7.5, containing 1 mM EDTA and 1.0 M NaCl.
c
Unless otherwise noted, refolding reactions were conducted in 0.1 M sodium phosphate buffer, pH 7.5, containing 1 mM EDTA and the reagents
indicated. Renaturation following heat treatment of vitronectin occurred as the protein was cooled to room temperature, and samples were
analyzed after refolding for at least 5 h. Renaturation following urea treatment of vitronectin was achieved after removing urea by overnight
dialysis of the protein into 0.1 M sodium phosphate buffer, pH 7.5, containing 1 mM EDTA and the other additives listed.
d
Errors in percent multimer are 65%.
e
The pH of 0.5 M arginine solutions in buffer or dH2O was adjusted to 7.5 with HCl.
f
The 18-residue synthetic peptide representing amino acids 346 to 363 within the heparin-binding sequence of vitronectin (see under
“Experimental Procedures”).
g
For heat treatment, protein was incubated at 55 °C for 1 h in 0.1 M sodium phosphate buffer, pH 7.5, containing 1.5 M NaCl and 1 mM EDTA.
Upon cooling in the high salt solution, the protein was monomeric. The salt concentration in the solution was adjusted to 0.15 M NaCl by
ultrafiltration into standard phosphate buffer before analysis by HPLC. For urea treatment, protein was incubated in 5 M urea overnight and then
subsequently refolded by ultrafiltration into 0.1 M sodium phosphate buffer, pH 7.5, containing 1.5 M NaCl and 1 mM EDTA. After refolding in 1.5
M NaCl, the protein was dialyzed into standard phosphate buffer to verify the stability of the refolded monomer.
h
Native vitronectin in standard phosphate buffer was incubated at room temperature for up to 48 h with the indicated concentrations of either
heparin or the 18-residue peptide. HPLC analysis at all time points indicated that a monomeric species was present, with no evidence for
multimerization under these conditions.
i
Multimeric vitronectin was treated with 1.0 M NaCl at room temperature for up to 48 h to test for salt-induced dissociation of the multimer.
HPLC analysis at all time points indicated no dissociation of the multimer under these conditions.
a

3 the Kd for the heparin-vitronectin interaction,5 a concentration which does not significantly affect the ionic strength of the
solution. Furthermore, if the heparin-binding region is involved in self-association of vitronectin, it was reasoned that
binding of subsaturating amounts of heparin should interrupt
the hypothesized ionic interactions between the C-terminal
basic region and N-terminal acidic residues (23). According to
the proposed model, which has been widely adopted in spite of
a paucity of experimental evidence in support, binding of heparin at the C-terminal basic region would expose the N-terminal acidic multimerization site and promote self-association.
This was not observed, and native protein remained in a monomeric form following incubation of 1 mgzml21 vitronectin
with 5 mM heparin for up to 48 h (Table III). Consistently,
Stockmann and co-workers (11) also observed that incubation
of native vitronectin with heparin does not induce multimer
formation.
In a similar experimental design, an 18-residue peptide
5
P. Zhuang, A. I. Chen, and C. B. Peterson, manuscript in
preparation.

which represents the heparin-binding sequence of vitronectin
was tested to determine whether it would affect partitioning of
denatured vitronectin between a monomeric and multimeric
form upon renaturation. If this region of the protein is involved
in self-association, the peptide should compete with the same
site on vitronectin for binding sites of opposite charge on other
chains which assemble to form the multimer. The peptide is
present at an approximate 40-fold excess over vitronectin, so it
should compete effectively for potential intermolecular binding
sites which stabilize the multimer, if, indeed, these interactions
are important for self-association. However, the peptide had no
effect on the exclusive formation of a multimeric species upon
refolding at physiological ionic strength. Also, incubation of the
peptide with native vitronectin in standard phosphate buffer
for long time periods did not promote oligomerization of the
protein. These results are summarized in Table III.
The effect of heparin on the kinetics of formation of the
multimer in renaturation experiments is shown in Fig. 9. In a
buffer of physiological ionic strength, a refolded form of the
protein that has a molecular size characteristic of the monomer
is observed transiently. Most of the vitronectin monomers
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FIG. 7. Conformational changes associated with the altered
form of vitronectin are prevented upon heat treatment with
L-arginine. Native vitronectin was heat treated at 55 °C for 1 h in the
presence of varying concentrations of L-arginine. Expression of the mAb
8E6 epitope was determined by competitive ELISA and results are
expressed as percentage of prevention of epitope expression (see “Experimental Procedures”). Inset, native vitronectin was heat treated in
the presence of phosphate-buffered saline (lane 2), or concentrations of
L-arginine equal to 50 mM (lane 3), 100 mM (lane 4), 200 mM (lane 5), 300
mM (lane 6), 400 mM (lane 7), or 500 mM (lane 8). Untreated vitronectin
is shown in lane 1. Samples were fractionated by native PAGE and
analyzed as in Fig. 4. The interface between stacking and separating
gels is shown by the arrowheads.
TABLE IV
Prevention of exposure of conformationally sensitive epitopes by amino
acids and NaCl
Antibody

Epitope

Conditionsa

% Prevention
of epitope
expressionb

MAb 153

Amino acids 1–40

Gly
L-Arg
L-Glu
0.5 M NaCl

0
61
71
69

mAb 8E6

Amino acids 52–239

Gly

0
67
83
75

L-Arg
L-Glu

0.5

M

NaCl

FIG. 8. GdnHCl unfolding curves for refolded monomers isolated following thermal or chemical denaturation and refolding
of vitronectin in 1.5 M NaCl. Unfolding curves are shown for refolded
monomers generated upon refolding after heat (open triangles) or chemical (solid circles) denaturation. Heat-treated vitronectin (5 mM) was
prepared by heating protein in 0.1 M sodium phosphate, pH 7.5, containing 1.5 M NaCl and 1 mM EDTA, at 55 °C for 2 h, followed by cooling
on ice. Chemical denaturation of vitronectin was performed by treatment of protein at a 5 mM concentration with 8 M urea in standard
phosphate buffer; refolding of the urea-treated protein was achieved by
dialysis into 0.1 M sodium phosphate buffer, pH 7.5, containing 1 mM
EDTA and 1.5 M NaCl. Refolded monomers were diluted to a 0.5 mM
concentration in mixtures containing various concentrations of GdnHCl
in standard phosphate buffer plus 0.04% Tween 20. Unfolding was
estimated from fluorescence emission spectra by calculating the intensity-averaged emission wavelength, as described under “Experimental
Procedures.” Following overnight incubation of vitronectin at each concentration of denaturant in buffer, emission spectra were recorded from
300 to 450 nm using an excitation wavelength of 290 nm. Data are
expressed as Fapp, the apparent fraction unfolded, by normalization of
individual readings to lF and lU as given in Table II.

a

Native vitronectin was heat-treated in the presence of the indicated
amino acids (500 mM final concentration) or 0.5 M NaCl for 1 h at 55 °C.
b
The competition of the heat-treated protein for binding of conformationally sensitive mAbs to wells precoated with denatured vitronectin was determined by a competitive ELISA method as described in the
legend to Fig. 7. Results are expressed as percentage of prevention of
epitope expression as defined under “Experimental Procedures.” Duplicate measurements varied less than 10%.

which are initially present progressively oligomerize into a
multimeric form. The half-life for assembly under these experimental conditions is approximately 8 h. Note that the monomer does not completely self-associate into a multimeric form
over the duration of this experiment, in which refolding is
conducted in 0.5 M urea. Recall that low concentrations of
chaotropic agents are disruptive to the oligomeric structure of
multimeric vitronectin, inducing dissociation into monomers
(12). Thus, it would be expected that the presence of denaturant upon refolding would bias the monomer/multimer distribution so that some monomers persist under these conditions.
At very high concentrations of heparin, equal to 1 mM, the
kinetics of self-association of vitronectin and partitioning between monomeric and multimeric forms are affected. As in
buffer without heparin, a refolded species which elutes as a
monomer is observed initially; the rate of self-association of
this intermediate form of vitronectin into a multimer is decreased upon addition of extremely high concentrations of heparin which equal 500 3 the Kd for the heparin-vitronectin
interaction.5 The half-life for self-association is estimated to be

FIG. 9. Kinetics of self-association of refolded vitronectin in
the absence and presence of added heparin. Vitronectin (1
mgzml21) was unfolded in 5 M urea in standard phosphate buffer, and
refolding was initiated by diluting the protein 10-fold in standard
phosphate buffer plus or minus 1 mM heparin. At various times after
refolding was initiated, 20-ml samples were injected onto the SEC2000
column and chromatographed by HPLC in standard phosphate buffer.
Multimerization in the absence of heparin is shown squares, and in the
presence of added heparin with circles. Peaks on a printed copy of the
elution profile with elution times of 5.6 and 6.8 min, corresponding to
the multimer and monomer, respectively, were integrated manually by
weight. Fraction monomer is plotted on the y axis as a function of time.
Lines drawn through the data are for illustrative purposes and do not
represent fits to exponentials.

increased approximately 2-fold to near 20 h. Notably, the oligomerization process to form the multimer is not prohibited,
with an equal partitioning between multimer and monomer
over the time course of this refolding experiment. The distribution between monomer and multimer upon refolding is per-
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turbed so that a higher fraction of monomer is observed compared to refolding in buffer of physiological ionic strength and
low concentrations of urea. This partitioning is reminiscent of
the distribution observed at NaCl concentrations intermediate
between physiological concentrations and 1.5 M NaCl. Since
heparin itself is a polyelectrolyte, the refolding to a monomeric
fraction in addition to the multimeric form is likely a function
of ionic strength. Indeed, the ionic strength of a 1 mM heparin
solution was calculated to approximately equal 0.88 (data not
shown). Clearly, the heparin-binding site on vitronectin, which
is saturated with ligand under these conditions, cannot participate in self-association into the multimeric form.
DISCUSSION

The biophysical analyses presented in a accompanying article (12), which were used to characterize the in vitro unfolding,
refolding, and multimerization behavior for vitronectin, were
expanded in this work to investigate the mechanism by which
vitronectin self-associates. Particular attention was paid to the
effects of varying redox conditions and ionic strength on the
self-association of vitronectin upon refolding. As summarized
in Scheme 1, the monomeric form of vitronectin isolated from
human plasma partially unfolds at intermediate concentrations of denaturant to an altered conformation with a high
propensity to associate into multimers. Likewise, refolding of
vitronectin proceeds via the partially folded intermediate
which highly prefers the branch pathway in Scheme 1 leading
to multimer formation over the pathway leading to a folded
monomeric form. Since monomeric and multimeric forms of
vitronectin are associated with different tissues, folding of
vitronectin in vivo appears to be regulated by partitioning of
folding intermediates via these pathways to either of two conformations, one that exists as a stable monomer and another
that associates into a multimeric form. Discussion of the results and conclusions drawn from this work is organized according to the questions posed in the Introduction.
Does Intramolecular Disulfide Rearrangement Stabilize an
Alternative Fold with a Tendency to Multimerize?—Intermolecular disulfides do not appear to make an important contribution to stabilizing the multimeric form of vitronectin, since
disulfides do not uniformly cross-link the vitronectin protomers
within the multimeric form. Unfolding of native vitronectin by
chaotropes exposes two buried sulfhydryls which presumably
promote the inter- and intramolecular rearrangement which
has been observed among some of the 14 cysteines in vitronectin. In order to establish that disulfide cross-links were not
essential for stabilization of multimeric vitronectin, Bittorf et
al. (9) conducted experiments intended to limit disulfide exchange upon denaturation. These investigators blocked available free sulfhydryls on native vitronectin with N-ethylmaleimide prior to unfolding in urea and refolding to generate
multimeric vitronectin. Since Bittorf and co-workers (9)
blocked available sulfhydryls on the native protein, which is
devoid of free sulfhydryls, potential disulfide rearrangement
upon denaturation would not have been avoided in their experiments. This presumably accounts for the observation by these
investigators that the average molecular weight of the constituent subunits isolated following dissociation of the multimer
was equal to 130,000, considerably higher than the molecular
weight expected for monomeric vitronectin. This molecular
weight is in fair agreement with that from ultracentrifugation
experiments presented in the accompanying article (12), in
which the higher molecular weight is attributed to a mixture of
vitronectin monomers and a small fraction of disulfide crosslinked species which assemble to form the multimer.
In a series of experiments designed to test the possibility
that perturbed disulfide-bonding patterns in vitronectin con-
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tribute to an altered fold which is prone to multimerize, redox
conditions were varied in order to find conditions which prevent the rearrangement of the C-terminal disulfide linking the
62,000 and 10,000 polypeptides comprising the two-chain form
of vitronectin. Strongly oxidizing conditions employed during
chemical denaturation of vitronectin were found to be effective
at preventing the disruption of the distal disulfide bond(s)
normally associated with denaturation. However, precluding
disruption of the covalent link between the 62,000 and 10,000
polypeptide chains was not sufficient to achieve reversibility in
unfolding and refolding of vitronectin in vitro. Hysteresis comparing unfolding and refolding curves in GdnHCl is still apparent, so unfolding and refolding apparently proceed via different
pathways, even when disulfide rearrangement is avoided. The
hypothesis that an altered disulfide-bonded fold may promote
intermolecular interactions in formation of multimeric
vitronectin is not supported by these results. Alternatively,
perturbations in folding at sites within the protein which are
not particularly sensitive to the presence or absence of native
disulfides appear to characterize the partially folded intermediate which has a propensity to oligomerize.
Conclusions about the role of disulfide rearrangement and
its effect in stabilizing an altered conformation which is prone
to self-association must acknowledge the limitations of the
experimental measurements which measure disulfide shuffling
in the protein. Assays which have been used in this work and
by others (7–9) are solely sensitive to disruption of the distal
disulfide(s) which covalently link the 62,000 and 10,000
polypeptides of two-chain vitronectin. The identity of the disulfide(s) which cross-link the heavy and light chains of
vitronectin is not known. Furthermore, it has not been rigorously established whether other disulfide rearrangements accompany disruption of the distal C-terminal disulfides. It is
unclear whether denaturation of vitronectin under highly oxidizing conditions promotes limited disulfide rearrangement
that is not propagated to the C-terminal disulfides.
Are There Conditions Which Favor Refolding of Vitronectin to
a Monomeric Form without Self-association as a Prominent
Side Reaction?—For the first time, conditions have been found
which disfavor self-association upon refolding of vitronectin in
vitro so that a monomeric species can be recovered after denaturation. The irreversibility of changes which are induced by
denaturation had been observed without exception, from the
early work of Barnes et al. (1), on changes in heparin-binding
properties of vitronectin, and Tomasini and Mosher (7, 8), on
changes detected immunochemically, to the more recent studies in which self-association irrevocably accompanies denaturation/renaturation of the protein using physiological renaturation conditions (9, 11–13). However, it has now been
established that high concentrations of charged amino acids or
NaCl included during refolding reactions are effective at prohibiting assembly into a multimeric form. Since both charged
amino acids and NaCl have similar influences which favor
refolding to a monomeric vitronectin, the effects are presumed
to result from increased ionic strength of the refolding medium.
What Effect do Charged Biomolecules or Salts Have on the
Distribution of Refolded Vitronectin between Monomeric and
Multimeric Forms?—Remarkably, the refolded monomer acquired upon renaturation at high ionic strength is stable, so
that ions can be removed by dialysis, and the protein retains its
monomeric character. The observation that removal of high
salt from the medium (after refolding has been achieved) does
not lead to multimer formation indicates that it is the pathway
for refolding, rather than the final folded product, which is
being influenced by the ionic strength effects. Another way to
construe this argument is to consider that ionic strength effects
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are exerted on the partially folded vitronectin species at the
branch point which determines whether the final refolded product will be monomeric or multimeric in nature. It is helpful to
consider these possibilities with regard to Scheme 1 as drawn;
high ionic strengths disfavor partitioning toward the multimeric species and clearly favor the refolding pathway that restores vitronectin to its initial monomeric form. It is only under
these higher ionic strength conditions that there is a true
equilibrium distribution between multimer and monomer, justifying the reversible reactions between V, V*, and Mv depicted
in the scheme.
Reversibility of the folding/unfolding equilibria in Scheme 1
are supported by the immunochemical and analytical characterization of vitronectin species undertaken in this work. As
already discussed, the analytical gel filtration results clearly
demonstrate that the refolded vitronectin species is identical in
molecular size to the native monomer. In the presence of high
arginine or NaCl concentrations, epitopes exposed in the altered conformation of vitronectin which is prone to multimerization are not expressed. By these criteria, the native and
refolded proteins are indistinguishable. Furthermore, GdnHCl
unfolding curves which are monitored by changes in the intrinsic fluorescence of vitronectin demonstrate that proteins that
are refolded at high ionic strengths subsequent to thermal or
chemical denaturation exhibit identical unfolding behavior. In
other words, the refolded structure acquired at high ionic
strength is the same regardless of the denaturation method
used to unfold the protein initially. This result is in stark
contrast to the observation that renaturation of thermally or
chemically denatured vitronectins in physiological ionic
strength yields multimers that are clearly different with respect to molecular size and sensitivity to denaturation (12).
What Contributions Do Ionic and Hydrophobic Interactions
Make to the Process of Self-association of Vitronectin?—The
types of interactions which contribute prominently to self-association for vitronectin are not fully evident from the ionic
strength data for several reasons. First, partitioning between
the two branch pathways from V* in Scheme 1 involves intermolecular interactions to form Mv and solely intramolecular
interactions to refold to V. Therefore, the influence of solvent
conditions to favor intra- versus intermolecular interactions
must be considered. Second, the effects of ions in the medium
are opposite for ionic interactions, which are disrupted by solvent ions, and hydrophobic interactions, which are strengthened at high ionic strength. A naive interpretation of the ionic
strength effects on partitioning of refolded vitronectin between
multimers and monomers would be that hydrophobic interactions do not appear to be the driving force for self-association,
as these interactions should be relatively strong in high salt.
Ionic interactions would perhaps be more important. Were this
interpretation of the data adequate, it would be anticipated
that treatment of multimeric vitronectin with high salt should
dissociate the protein into monomeric constituent chains. This
was not observed in practice, indicating that intermolecular
interactions within the multimer are not exclusively ionic in
nature.
It is more meaningful to consider the ionic strength effects as
they influence the folding intermediate, V*. Note that V* is
monomeric, a precursor to self-assembled forms of vitronectin.
In high ionic strengths, this intermediate experiences the same
effects described above, namely weakened ionic interactions
and strengthened hydrophobic forces. Hydrophobic collapse is
considered to be a driving force in acquisition of protein structure, and high ionic strength should favor intramolecular hydrophobic interactions which lead to formation of a stable hydrophobic core. Ionic interactions are probably less important

in the initial stages of folding and do not contribute significantly to the hydrophobic core of a protein. For the partially
folded intermediate, V*, a refolding medium containing high
salt should favor collapse of the hydrophobic core which presumably directs the folding of the monomer. Potential hydrophobic interactions with other partially folded vitronectin
chains, which may indeed stabilize Mv, are not as highly favored as intramolecular interactions due to entropic considerations. In other words, intramolecular events are favored over
diffusion-limited processes under these solvent conditions.
Strengthening of the hydrophobic effect for the monomeric
intermediate, V*, is thus proposed to be the principal determinant of partitioning V* toward a multimeric or monomeric
form. Further experimentation will be necessary to determine
whether inter- versus intramolecular hydrophobic forces indeed predominate in determining the refolding pathway for
vitronectin.
Does the Heparin-binding Region of Vitronectin Contribute
Intermolecular Interactions Which Participate in Oligomerization to the Multimeric Form?—Other workers have also suggested that both hydrophobic and ionic bonds are disrupted
upon unfolding of vitronectin (11), and furthermore, contribute
to assembly of the multimer (13). Partial proteolysis of
vitronectin within the heparin-binding region was observed to
preclude self-association, supporting the idea that the heparinbinding region is involved in intermolecular interactions between vitronectin chains. The arguments were taken further to
suggest that basic residues near the C-terminal heparin-binding site, as well as acidic residues, near the N terminus of the
protein, comprise parts of the multimerization sites (11).
These conclusions were re-evaluated by taking a somewhat
different approach in this study. Experiments were conducted
in which either saturating concentrations of heparin or 500 mM
concentrations of a peptide from the heparin-binding site of
vitronectin were included upon refolding of vitronectin following thermal denaturation. It was reasoned that saturation of
the protein with heparin would block the heparin-binding site
on the protein and interfere with its proposed participation in
the multimerization process. Likewise, binding of the heparinbinding peptide should occur at sites on vitronectin which are
complimentary and which comprise part of the multimerization
sites, as proposed by Stockmann et al. (11). Although it has
been suggested in the literature that acidic residues near the N
terminus interact with basic residues within the heparin-binding site, there is no experimental evidence to support this
contention, and potential binding sites for the basic peptide
have not been identified. The heparin-binding peptide used in
this study did not promote self-association by binding to
vitronectin; neither did it preclude self-association by competing for binding sites on other vitronectin chains during the
oligomerization process. The refolding experiments demonstrate that neither heparin, nor the peptide, prevented formation of multimeric vitronectin, disproving the hypothesis that
parts of the heparin-binding site provide multimerization interfaces for self-assembly.
Conclusions—In summary, the mechanism for unfolding/refolding and self-association of vitronectin has been evaluated in
this study. Effects of inter- and intramolecular disulfide rearrangement, which normally accompany denaturation of the
protein, are not the sole deterrent to reversibility of unfolding/
refolding of monomeric vitronectin. However, high ionic
strengths favor reversible refolding of denatured vitronectin to
a monomeric form and prevent self-association into a multimeric form. Ions apparently influence the pathway for refolding
via effects on a partially folded intermediate. High ion concentrations strengthen hydrophobic interactions within the hydro-
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phobic core that drives folding of the monomer; the effect is
much greater on intramolecular hydrophobic forces than for
potential hydrophobic interactions between chains that assemble to form the multimer. Although there may be both ionic and
hydrophobic interactions involved in oligomerization of
vitronectin, the heparin-binding site near the C terminus of the
protein does not appear to contribute binding interactions in
the multimer.
Proper redox conditions have been observed to be important
for correct in vitro folding of proteins in many cases. Optimized
redox conditions using a mixture of oxidized and reduced glutathione have been effective at reactivation of antibodies from
a completely unfolded and reduced state, providing conditions
which allow for correct disulfide formation (24 –26). It is interesting to note that urea or L-arginine were also used as additives in these experiments to suppress aggregation as a side
reaction. Folding of vitronectin in vivo is controlled by accessory factors and intracellular targeting, and the expression of
monomeric versus multimeric forms of the protein with different functional properties is tissue-specific. The set of helper
proteins that may assist vitronectin folding in vivo include
folding catalysts, such as peptidyl-prolyl isomerase and protein
disulfide isomerase, and chaperones, such as those in the
Cpn60 and Cpn70 classes.6 The work cited above concerning
refolding of antibodies was expanded to demonstrate that addition of protein disulfide isomerase during in vitro refolding
reactions facilitates formation of correct disulfides (27). Furthermore, the effects of protein disulfide isomerase in vitro
have been observed to parallel acquisition of native disulfide
bonds in vivo in cases where in vitro and in vivo pathways have
been characterized (19). It should be interesting to test in vitro
effects of protein disulfide isomerase on the refolding of human
vitronectin.
As this discussion has progressed, points for future work
have become apparent and many questions remain to be answered. For example, is the monomer acquired upon refolding
at high ionic strength folded identically to native vitronectin
isolated from plasma? Are all of the native disulfide bonds
intact? Does the refolded monomer exhibit the same functional
properties, especially in terms of macromolecular interactions,
that native vitronectin exhibits? Do vitronectin monomers and
multimers contain unique arrangements of oxidized and reduced sulfhydryls within the two populations of vitronectin
species? What specific interactions contribute to stabilization
at interfaces between vitronectin subunits in the multimer?
How does the fold of the native monomer differ from that of the
individual vitronectin chains which comprise the multimer?
Partial answers to these questions can be gained by determin6
In vitro experiments in which the molecular chaperone GroEL (a
molecular chaperone in the Cpn60 class) was included upon initiation of
refolding did not affect the observed self-association of refolded
vitronectin exclusively into a multimeric form.
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ing the disulfide-bonded structure of native and conformationally-altered vitronectin. The potential for using site-directed
mutagenesis on vitronectin to analyze folding properties and
intermolecular interactions is great now that vitronectin can be
expressed in a recombinant form (28, 29). Since the self-association exhibited by vitronectin to acquire a multivalent nature
is a property shared by many of the adhesive glycoproteins
involved in hemostasis, a thorough understanding of the folding pathway for the protein and intra- and intermolecular
interactions which contribute to stabilization of the two forms
of vitronectin should be fruitful and relevant to regulation of
function in vivo.
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